Название: 40 Years of Continuous Renal Replacement Therapy
Автор: Группа авторов
Издательство: Ingram
Жанр: Медицина
Серия: Contributions to Nephrology
isbn: 9783318063073
isbn:
3Lauer A, Saccaggi A, Ronco C, Belledonne M, Glabman S, Bosch JP: Continuous arteriovenous hemofiltration in the critically ill patient. Clinical use and operational characteristics. Ann Intern Med 1983;99:455–460.
4Ronco C, Garzotto F, Ricci Z: CA.R.PE.DI.E.M. (Cardio-Renal Pediatric Dialysis Emergency Machine): evolution of continuous renal replacement therapies in infants. A personal journey. Pediatr Nephrol 2012;27:1203–1211.
5Ronco C: Arterio-venous hemodiafiltration (A-V HDF): a possible way to increase urea removal during C.A.V.H. Int J Artif Organs 1985;8:61–62.
6Ronco C, Fabris A, Feriani M, et al: Technical and clinical evaluation of a new system for ultrafiltration control during hemodialysis. ASAIO Trans 1988;34:613–616.
7Ricci Z, Bonello M, Salvatori G, Ratanarat R, Brendolan A, Dan M, et al: Continuous renal replacement technology: from adaptive devices to flexible multipurpose machines. Crit Care Resusc 2004;6:180–187.
8Ronco C, Bellomo R: The evolving technology for continuous renal replacement therapy from current standards to high volume hemofiltration. Curr Opin Crit Care 1997;3:426–433.
9Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26–30.
10Ricci Z, Salvatori G, Bonello M, et al: A new machine for continuous renal replacement therapy: from development to clinical testing. Expert Rev Med Devices 2005;2:47–55.
11Garzotto F, Ostermann M, Martín-Langerwerf D, Sánchez-Sánchez M, Teng J, Robert R, Marinho A, Herrera-Gutierrez ME, Mao HJ, Benavente D, Kipnis E, Lorenzin A, Marcelli D, Tetta C, Ronco C; DoReMIFA Study Group: The dose response multicentre investigation on fluid assessment (DoReMIFA) in critically ill patients. Crit Care 2016;20:196.
12Lorenzin A, Garzotto F, Alghisi A, Neri M, Galeano D, Aresu S, Pani A, Vidal E, Ricci Z, Murer L, Goldstein SL, Ronco C: CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations. Pediatr Nephrol 2016;31:1659–1665.
13Villa G, Ricci Z, Romagnoli S, Ronco C: Multidimensional approach to adequacy of renal replacement therapy in acute kidney injury; in Ding X, Ronco C (eds): Acute Kidney Injury From Diagnosis to Care.
Contrib Nephrol. Basel, Karger, 2016, vol 187, pp 94–105.
14Nalesso F, Giuliani A, Basso F, Brendolan A, Ronco C: [Timing and dose in renal replacement therapy]. Cir Cir 2013;81:177–180.
15Ricci Z, Ronco C: Renal replacement therapy in the critically ill: getting it right. Curr Opin Crit Care 2012;18:607–612.
16Ricci Z, Ronco C: Timing, dose and mode of dialysis in acute kidney injury. Curr Opin Crit Care 2011;17:556–561.
17Vesconi S, Cruz DN, Fumagalli R, Kindgen-Milles D, Monti G, Marinho A, Mariano F, Formica M, Marchesi M, René R, Livigni S, Ronco C; Dose Response Multicentre International Collaborative Initiative (DO-RE-MI Study Group): Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 2009;13:R57.
18Ronco C, Cruz D, Oudemans van Straaten H, Honore P, House A, Bin D, Gibney N: Dialysis dose in acute kidney injury: no time for therapeutic nihilism – a critical appraisal of the acute renal failure trial network study. Crit Care 2008;12:308.
19Ricci Z, Bellomo R, Ronco C: Dose of dialysis in acute renal failure. Clin J Am Soc Nephrol 2006;1:380–388.
20Monti G, Herrera M, Kindgen-Milles D, Marinho A, Cruz D, Mariano F, Gigliola G, Moretti E, Alessandri E, Robert R, Ronco C: The dose response multicentre international collaborative initiative (DO-RE-MI); in Ronco C, Bellomo R, Kellum JA (eds): Acute Kidney Injury. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 434–443.
21Reiter K, Bellomo R, Ronco C, Kellum JA: Pro/con clinical debate: is high-volume hemofiltration beneficial in the treatment of septic shock? Crit Care 2002;6:18–21.
22Ronco C, Bonello M, Bordoni V, Ricci Z, D’Intini V, Bellomo R, Levin NW: Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif 2004;22:164–174.
23Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S, Zamperetti N, Brendolan A, D’Intini V, Tetta C, et al: Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006;32:80–86.
24Reiter K, D’Intini V, Bordoni V, Baldwin I, Bellomo R, Tetta C, Brendolan A, Ronco C: High-volume hemofiltration in sepsis. Nephron 2002;92:251–258.
25Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d’Intini V, Bellomo R: Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 2003;27:792–801.
26Mariano F, Fonsato V, Lanfranco G, Pohlmeier R, Ronco C, Triolo G, Camussi G, Tetta C, Passlick-Deetjen J: Tailoring high-cutoff membranes and feasible application in sepsis-associated acute renal failure: in vitro studies. Nephrol Dial Transplant 2005;20:1116–1126.
27Ronco C, Brendolan A, D’Intini V, Ricci Z, Wratten ML, Bellomo R: Coupled plasma filtration adsorption: rationale, technical development and early clinical experience. Blood Purif 2003;21:409–416.
28Ronco C, Bellomo R: Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 2002;25:733–747.
29Ronco C: The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis. Crit Care 2005;9:631–633.
30Cruz DN, de Cal M, Piccinni P, Ronco C: Polymyxin-B hemoperfusion and endotoxin removal: lessons from a review of the literature; in Ronco C, Piccinni P, Rosner MH (eds): Endotoxemia and Endotoxin Shock. Contrib Nephrol. Basel, Karger, 2010, vol 167, pp 77–82.
31Kellum JA, Ronco C: The 17th acute disease quality initiative international consensus conference: introducing precision renal replacement therapy. Blood СКАЧАТЬ